Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer

por Guo, Lin-Wei, Jiang, Lin-Miao, Gong, Yue, Zhang, Hong-Hua, Li, Xiao-Guang, He, Min, Sun, Wei-Li, Ling, Hong, Hu, Xin
Publicado 2018

Large‐scale genomic sequencing reveals adaptive opportunity of targeting mutated‐PI3Kα in early and advanced HER2‐positive breast cancer

por Guo, Lin‐Wei, Li, Xiao‐Guang, Yang, Yun‐Song, Lu, Xun‐Xi, Han, Xiang‐Chen, Lang, Guan‐Tian, Chen, Li, Shao, Zhi‐Ming, Hu, Xin
Publicado 2021

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer

por Ji, Peng, Gong, Yue, Jin, Ming-liang, Wu, Huai-liang, Guo, Lin-Wei, Pei, Yu-Chen, Chai, Wen-Jun, Jiang, Yi-Zhou, Liu, Yin, Ma, Xiao-Yan, Di, Gen-Hong, Hu, Xin, Shao, Zhi-Ming
Publicado 2022

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

por Lang, Guan-Tian, Jiang, Yi-Zhou, Shi, Jin-Xiu, Yang, Fan, Li, Xiao-Guang, Pei, Yu-Chen, Zhang, Chen-Hui, Ma, Ding, Xiao, Yi, Hu, Peng-Chen, Wang, Hai, Yang, Yun-Song, Guo, Lin-Wei, Lu, Xun-Xi, Xue, Meng-Zhu, Wang, Peng, Cao, A-Yong, Ling, Hong, Wang, Zhong-Hua, Yu, Ke-Da, Di, Gen-Hong, Li, Da-Qiang, Wang, Yun-Jin, Yu, Ying, Shi, Le-Ming, Hu, Xin, Huang, Wei, Shao, Zhi-Ming
Publicado 2020